7,43 €
2,55 %gestern
L&S, 28. Februar, 22:53 Uhr
ISIN
US56600D1072
Symbol
MRVI
Berichte

Maravai LifeSciences Aktie News

Positiv
Seeking Alpha
6 Tage alt
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2023 Earnings Call Transcript
Neutral
GlobeNewsWire
6 Tage alt
Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation
Negativ
InvestorPlace
17 Tage alt
The unpredictable nature of the biotech industry, which frequently flirts with failure, underscores the inherent risks and rewards associated with doomed biotech stocks. The journey from drug discovery to market approval is notoriously long and uncertain.
Neutral
GlobeNewsWire
etwa ein Monat alt
SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2023 financial and operating results after the market closes on Thursday, February 22, 2024, and will host a conference call and webcast on the same day ...
Neutral
GlobeNewsWire
4 Monate alt
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of November.
Neutral
Seeking Alpha
4 Monate alt
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Deb Hart - Investor Relations Trey Martin - Chief Executive Officer Kevin Herde - Chief Financial Officer Drew Burch - President, Nucleic Acid Production Becky Buzzeo - Executive Vice President and Chief Commercial Officer Conference Call Participants Tejas Savant...
Neutral
GlobeNewsWire
4 Monate alt
SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2023 financial and operating results after the market closes on Tuesday, November 7, 2023, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ ...
Neutral
GlobeNewsWire
5 Monate alt
Highlights include the company's strong foundation for growth, focus on innovation and attractive long-term outlook Highlights include the company's strong foundation for growth, focus on innovation and attractive long-term outlook

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen